Citigroup’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.4K Sell
28,528
-36,777
-56% -$26.3K ﹤0.01% 4341
2025
Q1
$42.5K Buy
65,305
+1,381
+2% +$898 ﹤0.01% 4157
2024
Q4
$118K Buy
63,924
+2,784
+5% +$5.12K ﹤0.01% 3910
2024
Q3
$212K Buy
61,140
+41,951
+219% +$145K ﹤0.01% 3542
2024
Q2
$56.2K Buy
19,189
+7,606
+66% +$22.3K ﹤0.01% 3781
2024
Q1
$65.4K Buy
11,583
+2,910
+34% +$16.4K ﹤0.01% 3753
2023
Q4
$37.2K Buy
8,673
+7,848
+951% +$33.7K ﹤0.01% 3926
2023
Q3
$2.86K Sell
825
-18,154
-96% -$63K ﹤0.01% 4124
2023
Q2
$88.3K Sell
18,979
-153,152
-89% -$712K ﹤0.01% 3635
2023
Q1
$795K Buy
172,131
+128,437
+294% +$593K ﹤0.01% 2183
2022
Q4
$353K Buy
43,694
+42,398
+3,271% +$343K ﹤0.01% 2734
2022
Q3
$7K Sell
1,296
-2,643
-67% -$14.3K ﹤0.01% 4365
2022
Q2
$21K Sell
3,939
-24,732
-86% -$132K ﹤0.01% 4286
2022
Q1
$236K Sell
28,671
-44,271
-61% -$364K ﹤0.01% 3316
2021
Q4
$1.09M Buy
72,942
+30,437
+72% +$453K ﹤0.01% 2464
2021
Q3
$803K Sell
42,505
-95,096
-69% -$1.8M ﹤0.01% 2554
2021
Q2
$2.56M Sell
137,601
-31,993
-19% -$595K ﹤0.01% 1919
2021
Q1
$3.86M Buy
169,594
+119,623
+239% +$2.72M ﹤0.01% 1505
2020
Q4
$1.09M Buy
49,971
+48,726
+3,914% +$1.06M ﹤0.01% 2114
2020
Q3
$13K Sell
1,245
-980
-44% -$10.2K ﹤0.01% 4190
2020
Q2
$17K Sell
2,225
-844
-28% -$6.45K ﹤0.01% 4371
2020
Q1
$31K Buy
3,069
+887
+41% +$8.96K ﹤0.01% 4122
2019
Q4
$24K Buy
2,182
+1,189
+120% +$13.1K ﹤0.01% 4420
2019
Q3
$9K Sell
993
-1,837
-65% -$16.7K ﹤0.01% 4625
2019
Q2
$32K Buy
2,830
+1,127
+66% +$12.7K ﹤0.01% 4370
2019
Q1
$19K Buy
1,703
+18
+1% +$201 ﹤0.01% 4547
2018
Q4
$16K Buy
+1,685
New +$16K ﹤0.01% 4498